Connect Biopharma Holdings Limited · NASDAQ:CNTB

Xanthopoulos Kleanthis Gabriel received 3,738 Connect Biopharma Holdings Limited shares as an award (Form 4)

Traded Jun 30, 2026 · Filed Jul 1, 2026

On Jun 30, 2026, Xanthopoulos Kleanthis Gabriel (Director) received 3,738 Connect Biopharma Holdings Limited shares as an award, leaving 86,554 shares. Filed Jul 1, 2026 (Form 4).

Awarded
3,738 shares
Holding after
86,554 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 30, 2026Ordinary SharesAward3,73886,554Direct

Source

View original at SEC

Related